QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Workflow Configurator, enabling researchers in the life sciences to easily and quickly find the best solutions to optimize their experiments.
QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments
